ExodusPoint Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-262,134
Closed -$433K 1539
2024
Q3
$433K Buy
262,134
+155,412
+146% +$257K ﹤0.01% 1161
2024
Q2
$237K Buy
106,722
+23,322
+28% +$51.8K ﹤0.01% 1234
2024
Q1
$224K Buy
+83,400
New +$224K ﹤0.01% 1202
2023
Q2
Sell
-257,584
Closed -$410K 1856
2023
Q1
$410K Sell
257,584
-914,215
-78% -$1.46M ﹤0.01% 1294
2022
Q4
$7.3M Buy
1,171,799
+806,848
+221% +$5.03M 0.11% 238
2022
Q3
$2.45M Buy
364,951
+340,944
+1,420% +$2.28M 0.03% 675
2022
Q2
$153K Sell
24,007
-18,499
-44% -$118K ﹤0.01% 1646
2022
Q1
$197K Buy
42,506
+28,427
+202% +$132K ﹤0.01% 1860
2021
Q4
$70K Sell
14,079
-49,381
-78% -$246K ﹤0.01% 1956
2021
Q3
$765K Buy
+63,460
New +$765K 0.01% 1113